UniversityLibraryCurrent studentsStaff intranet
University of Sydney
University of Sydney
View Item 
  • Sydney eScholarship Home
  • Postgraduate Theses
  • Sydney Digital Theses (University of Sydney Access only)
  • View Item
  • Sydney eScholarship Home
  • Postgraduate Theses
  • Sydney Digital Theses (University of Sydney Access only)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Chemotherapy-Induced Cognitive Impairments: Targeting Neuroimmune Processes as Potential Treatments

Thumbnail
View/Open
Thesis (PDF, 3.33MB)
Date
2018-12-14
Author
Lucas, Antigone
Metadata
Show full item record
Abstract
Chemotherapy has prolonged the survival rates of cancer patients. However, chemotherapy causes peripheral neuropathies and cognitive impairments. Isolating which chemotherapy agents are responsible for these behavioural changes is difficult. Patients are given regimens that contain several agents alongside hormone therapy and radiation. Animal models are useful to elucidate which class of agents have the most neurotoxic effect and can determine which neural mechanisms are vulnerable to chemotherapy. Animal models can also determine which pharmacological agents reduce neurotoxic side effects to restore normal functioning. The first aim of this thesis was to compose a systematic review of chemobrain in animal models. The second aim was to explore the effects of oxaliplatin (OXP) on cognition in rodents. The third aim was to determine whether ibudilast (IBU), a proven immune therapy and nicotinamide mononucleotide (NMN), a permeable nicotinamide adenine dinucleotide precursor can reduce OXP-induced neurotoxicity. The systematic review showed that across all chemotherapy regimens short term memory (STM) was profoundly impaired. Impairments were associated with disrupted neurogenesis, oxidative stress, inflammation and altered neuronal morphology. The most cytotoxic regimens were cisplatin and methotrexate + 5-fluorouracil with or without cyclophosphamide. These regimens produced impairments in STM, long term memory and executive control. Experiments demonstrated that one injection of IBU or consumption of NMN for 7 days reduced OXP-induced object recognition memory impairments in acute and chronic pre-clinical models of OXP-induced neurotoxicity. Furthermore, OXP-treated rats showed intact object recognition memory at least 7 days post NMN treatment cessation. One injection of IBU also prevented OXP-induced tactile allodynia. These experiments highlight the therapeutic potential of IBU and NMN in reducing the neurotoxic side effects of platinum chemotherapy agents.
URI
http://hdl.handle.net/2123/20561
Collections
  • Sydney Digital Theses (University of Sydney Access only) [2943]

Browse

All of Sydney eScholarshipCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors

Links

University homeLibraryCurrent studentsStaff intranet

Repository

  • About us
  • FAQ
  • Policies & guidelines
  • Email us
  • Non-UniKey login
Leadership for good starts here

Media

  • News
  • Find an expert
  • Media contacts

Student links

  • Log in to University systems
  • Study dates
  • Student handbooks
  • Timetables
  • Library

About us

  • Our world rankings
  • Faculties and schools
  • Centres and institutes
  • Campus locations
  • Maps and locations

Connect

  • Contact us
  • Find a staff member
  • Careers at Sydney
  • Events
  • Emergencies and personal safety
Inspired: Campaign to support the University of SydneyGroup of Eight
Disclaimer
Privacy
Accessibility
Website feedback
ABN: 15 211 513 464
CRICOS Number: 00026A
Disclaimer
Privacy
Accessibility
Website feedback
ABN: 15 211 513 464
CRICOS Number: 00026A